Nurexone Biologic Inc (NRXBF)

$0.50 +0.01 (1.03%)
Market Cap 45.20M
Revenue (ttm) 0.00
Net Income (ttm) -5.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 10,000
Avg Vol 5,148
Day's Range N/A - N/A
Shares Out 90.68M
Stochastic %K 90%
Beta -0.47
Analysts Strong Buy
Price Target $3.50

Company Profile

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis caused by spinal cord injury using membrane-bound extracellular vesicles technology, as well...

Industry: Biotechnology
Sector: Healthcare
Address:
1 Adelaide Street East, Suite 801, Toronto, Canada
newsfile_corp
newsfile_corp Feb. 10 at 9:04 PM
https://nfne.ws/283437 $NRXBF $NRX.TSXV @NBiolo #Batchtobatchconsistency #CentralNervousSystem #ExosomebasedTherapy #ExosomeProduction #Reg
0 · Reply
NewsAndFilings
NewsAndFilings Feb. 6 at 10:54 PM
Biotech & Healthcare: $CSDX, $NWBO, $BSEM, $RDGL, $NRXBF Emerging Stocks to Watch https://thestreetreports.com/biotech-healthcare-csdx-nwbo-bsem-rdgl-nrxbf-emerging-stocks-to-watch/
1 · Reply
DiamondCapital
DiamondCapital Feb. 5 at 2:16 PM
News article out now!! Covering $CSDX, $NWBO, $BSEM, $RDGL, $NRXBF https://thestreetreports.com/biotech-healthcare-csdx-nwbo-bsem-rdgl-nrxbf-emerging-stocks-to-watch/ Biotech & Healthcare: CSDX, NWBO, BSEM, RDGL, NRXBF Emerging Stocks to Watch
2 · Reply
ZacksSCR
ZacksSCR Dec. 23 at 1:59 PM
$NRXBF Keeps Proving its Treatment is Superior https://buff.ly/rEAftZ0
0 · Reply
ZacksSCR
ZacksSCR Dec. 1 at 5:30 PM
$NRXBF Advances Toward Breakthrough Treatments https://buff.ly/IOVP92j
0 · Reply
emberlyWagner61
emberlyWagner61 Nov. 19 at 5:17 PM
$NRXBF (NurExone) exosome therapy for CNS injuries — deep tech, high optionality.
0 · Reply
TimRegan_WTR
TimRegan_WTR Oct. 31 at 5:20 PM
$NRXBF $NRX
0 · Reply
TimRegan_WTR
TimRegan_WTR Oct. 30 at 7:08 PM
$NRXBF $NRX
0 · Reply
ZacksSCR
ZacksSCR Oct. 27 at 1:41 PM
$NRXBF CEO Chat with Dr. Lior Shaltiel, CEO of NurExone Biologic Inc. https://buff.ly/X9rBUam
0 · Reply
ZacksSCR
ZacksSCR Oct. 13 at 3:17 PM
$NRXBF Treatment Restores Sight https://buff.ly/wmUU6iF
0 · Reply
Latest News on NRXBF
No data available.
newsfile_corp
newsfile_corp Feb. 10 at 9:04 PM
https://nfne.ws/283437 $NRXBF $NRX.TSXV @NBiolo #Batchtobatchconsistency #CentralNervousSystem #ExosomebasedTherapy #ExosomeProduction #Reg
0 · Reply
NewsAndFilings
NewsAndFilings Feb. 6 at 10:54 PM
Biotech & Healthcare: $CSDX, $NWBO, $BSEM, $RDGL, $NRXBF Emerging Stocks to Watch https://thestreetreports.com/biotech-healthcare-csdx-nwbo-bsem-rdgl-nrxbf-emerging-stocks-to-watch/
1 · Reply
DiamondCapital
DiamondCapital Feb. 5 at 2:16 PM
News article out now!! Covering $CSDX, $NWBO, $BSEM, $RDGL, $NRXBF https://thestreetreports.com/biotech-healthcare-csdx-nwbo-bsem-rdgl-nrxbf-emerging-stocks-to-watch/ Biotech & Healthcare: CSDX, NWBO, BSEM, RDGL, NRXBF Emerging Stocks to Watch
2 · Reply
ZacksSCR
ZacksSCR Dec. 23 at 1:59 PM
$NRXBF Keeps Proving its Treatment is Superior https://buff.ly/rEAftZ0
0 · Reply
ZacksSCR
ZacksSCR Dec. 1 at 5:30 PM
$NRXBF Advances Toward Breakthrough Treatments https://buff.ly/IOVP92j
0 · Reply
emberlyWagner61
emberlyWagner61 Nov. 19 at 5:17 PM
$NRXBF (NurExone) exosome therapy for CNS injuries — deep tech, high optionality.
0 · Reply
TimRegan_WTR
TimRegan_WTR Oct. 31 at 5:20 PM
$NRXBF $NRX
0 · Reply
TimRegan_WTR
TimRegan_WTR Oct. 30 at 7:08 PM
$NRXBF $NRX
0 · Reply
ZacksSCR
ZacksSCR Oct. 27 at 1:41 PM
$NRXBF CEO Chat with Dr. Lior Shaltiel, CEO of NurExone Biologic Inc. https://buff.ly/X9rBUam
0 · Reply
ZacksSCR
ZacksSCR Oct. 13 at 3:17 PM
$NRXBF Treatment Restores Sight https://buff.ly/wmUU6iF
0 · Reply
OptionJunkie36
OptionJunkie36 Sep. 19 at 12:45 PM
$NRXBF hello all. Please excuse the silly questions. I'm a newb here regard this stock. Heard about it on Israeli broadcasted news. But my question is about human trails. Looks like that are just about to start that. Did I get that right?
0 · Reply
ZacksSCR
ZacksSCR Sep. 10 at 3:24 PM
$NRXBF $NRX.TSX Gets Patent for Exciting Cell Technology https://buff.ly/qJQqBwX
0 · Reply
BioAmerica
BioAmerica Aug. 21 at 10:51 AM
$NRXBF $XBI $IBB This is some interesting results. Anyone looking for an early stage biotech should look at NRXBF. A ways to go, but this could be very interesting in the years to come. Do your own DD and make sure this fits you investment profile.
0 · Reply
ZacksSCR
ZacksSCR Aug. 11 at 3:21 PM
$NRXBF $NRX.TSX Treatment Shows Remarkable Treatment Properties https://buff.ly/5ZUxNcF
0 · Reply
Northern_Lightz
Northern_Lightz Aug. 11 at 2:48 PM
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard $NRXBF https://www.globenewswire.com/news-release/2025/08/08/3130357/0/en/NurExone-s-Exosomes-Show-Stronger-Healing-Potential-Than-Industry-Standard.html
0 · Reply
FRCresearch
FRCresearch Jul. 21 at 11:15 PM
$NRXBF Disseminated on behalf of NurExone Biologic Inc. (TSXV: NRX / OTCQB: NRXBF / FSE: J90). Update: @NBiologic’s ExoPTEN showed strong preclinical results, improving motor function in spinal cord injury models. Read our analyst note on NurExone’s ExoPTEN preclinical success: https://www.researchfrc.com/content/analyst-ideas/post/302/top-picks-snapshot-tech-mining-movers
0 · Reply
Northern_Lightz
Northern_Lightz Jul. 10 at 5:37 PM
$NRXBF: Test Results Show Spinal Injury Recovery https://pdfhost.io/v/eKEMku7LuY_NRXBF-_Test_Results_Show_Spinal_Injury_Recovery
0 · Reply
ZacksSCR
ZacksSCR Jul. 9 at 8:38 PM
$NRXBF Treatment Restores Mobility to Spinal Injury Patients https://buff.ly/WG5yt3m
0 · Reply
Northern_Lightz
Northern_Lightz Jul. 9 at 5:18 PM
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model $NRXBF https://www.globenewswire.com/news-release/2025/07/08/3112213/0/en/New-ExoPTEN-Preclinical-Study-Indicates-Significant-Improvement-in-Walking-Quality-in-Spinal-Cord-Injury-Model.html
0 · Reply
Northern_Lightz
Northern_Lightz Jun. 20 at 12:29 PM
NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update $NRXBF https://www.globenewswire.com/news-release/2025/06/20/3102535/0/en/NurExone-Advances-U-S-Growth-Strategy-with-Acceptance-into-Prestigious-ARMI-HealthTech-Hub-Accelerator-and-Provides-Corporate-Update.html
0 · Reply